Delivery Order SPE2DR25D1100-SPE2DR26FCR3F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,975.75 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100 count) on December 26, 2025, with an ultimate completion date of December 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $27,638.41 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a completion date of August 25, 2025. This is a firm fixed-price delivery order under a non-set-aside competition, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,767.42 on December 18, 2025, for the supply of Prograf 1 mg capsules (100-count units). This is a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Prograf 1 mg with a ceiling value of $4,739.73. This competitively awarded, firm fixed-price delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,663.57 on October 20, 2025, for the supply of Prograf 0.5 mg capsules (100-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. This delivery order...
- The Defense Logistics Agency awarded a $1,738.12 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Prograf 1 mg capsules (100-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prograf 1 mg capsules (100-count units) on November 5, 2025, with a ceiling value of $5,083.18. This non-competitive, firm fixed-price delivery order is expected to be completed by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,120.30 to supply 100 capsules of Prograf 0.5 mg, a pharmaceutical product used in immunosuppressive therapy. The contract, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award through the federal procurement process. Performance will be fulfilled from AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,638.85 to AmerisourceBergen Drug Corp for the supply of Prograf 5 mg capsules (100 count) on November 3, 2025, with completion scheduled for November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Prograf 1 mg capsules in quantities of 100 units. This contract, which is a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX, valued at $999.9 million through December 2026), carries a ceiling value of $2,747.52 and employs firm fixed-price pricing with no set-aside designation. The product will be...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCR3FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Prograf 1 mg capsules (100-count units) under a firm fixed price contract valued at $10,775.30, with an ultimate completion date of November 26, 2025. This non-set-aside award was competitively awarded and represents a single delivery order transaction for pharmaceutical procurement to support federal medical supply needs, particularly for military and veteran healthcare systems. The place of performance is located at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026. As a prime vendor, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide, including vaccines, brand-name and generic medications, and specialized medical supplies. The company's track record of competitively awarded federal contracts demonstrates its capability to fulfill diverse and variable federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 11/24/25 |